• GHANSHAMDAS R. BAIRAGI SRES’ Sanjivani College of Pharmaceutical Education and Research, Kopargaon 423603, Maharashtra, India
  • VIPUL P. PATEL SRES’ Sanjivani College of Pharmaceutical Education and Research, Kopargaon 423603, Maharashtra, India



Curcumin, Microemulsion, Emulgel, Candida albicans, Fluconazole, In vitro permeability, Antifungal assay


Objective: The main causative agent of vaginal candidiasis is Candida albicans and it develops resistance against several synthetic antifungal drugs and it has a high rate of infection in women. According to WHO report, around 75% of women are infected by Candida albicans and 50 % are infected a second time by Candida albicans. Therefore, we choose Curcumin an antifungal agent that had reported antifungal properties against the various fungal species. The Curcumin-containing emulgel based microemulsion system was prepared for greater retention time and penetration across the vaginal mucosa.

Methods: The screening of oil phase, surfactant, and cosurfactant for microemulsion formulation was selected based on the solubility study and followed by the construction of the pseudoternary phase diagram. The oil phase, surfactant and co-surfactant are selected from the pseudoternary phase diagram for the formulation of a stable microemulsion. The prepared Curcumin-loaded microemulsion was characterized by globule size, polydispersity index, Zeta potential, accelerated stability study, drug content, percent transmittance and antifungal assay by broth microdilution technique. The formulated microemulsion was converted into a vaginal emulgel by using Pluronic@F127. The formulated curcumin-loaded emulgel was characterized by different evaluation parameters and antifungal study by agar well diffusion method.

Results: The result showed that the average globule size of emulgel was 286.3 nm, polydispersity index was 0.241, Zeta potential was+19.20 mv, conductivity was 0.0390 mS/cm, and drug content was found to be 95.58%. The texture of formulated emulgel was found to be soft and smooth, with shear-thinning, pseudoplastic behavior, and easily spreadable. The in vitro permeability study of emulgel shows slow and complete release of curcumin in 10 h. The microemulsion and developed emulgel showed promising antifungal activity against Candida albicans.

Conclusion: The developed curcumin-loaded emulgel showed promising antifungal activity against Candida albicans as compared to the Fluconazole as an standard antifungal antibiotic. Our formulated Curcumin-containing emulgel can be a potential alternative as compared to the conventional dosage form for the treatment of vaginal candidiasis.


Download data is not yet available.


Nagashima M, Yamagishi Y, Mikamo H. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis. J Infect Chemother. 2016;22(2):124-6. doi: 10.1016/j.jiac.2015.08.008, PMID 26627336.

Palmeira-de-Oliveira R, Palmeira-de-Oliveira A, Martinez-de-Oliveira J. New strategies for local treatment of vaginal infections. Adv Drug Deliv Rev. 2015;92:105-22. doi: 10.1016/j.addr.2015.06.008, PMID 26144995.

Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998;178(2):203-11. doi: 10.1016/s0002-9378(98)80001-x, PMID 9500475.

Alsamydai A, Jaber N. Pharmacological aspects of curcumin: review article. Int J Pharmacogn. 2018;5(6):313-26.

Andrade JT, Fantini de Figueiredo G, Cruz LF, Eliza de Morais S, Souza CDF, Pinto FCH, Ferreira JMS, Araújo MGF. Efficacy of curcumin in the treatment of experimental vulvovaginal candidiasis. Rev Iberoam Micol. 2019;36(4):192-9. doi: 10.1016/j.riam.2019.01.003, PMID 31757595.

Talegaonkar S, Azeem A, Ahmad FJ, Khar RK, Pathan SA, Khan ZI. Microemulsions: A novel approach to enhanced drug delivery. Recent Pat Drug Deliv Formul. 2008;2(3):238-57. doi: 10.2174/187221108786241679, PMID 19075911.

Sreevidya VS. An overview on emulgel. Int J Pharm Phytopharmacol Res. 2019;9(1):92-7.

Thakkar V, Shah A. Optimization of self microemulsifying drug delivery system containing curcumin and artemisinin using D-optimal mixture design. Saudi J Pharm Sci 2017;3(5):388-98.

Hu L, Jia Y, Niu F, Jia Z, Yang X, Jiao K. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle. J Agric Food Chem. 2012;60(29):7137-41. doi: 10.1021/jf204078t, PMID 22587560.

Zhao Y, Ding W, Wei J. Preparation of a bis-demethoxy curcumin microemulsion based on pseudo-ternary phase diagrams and an orthogonal test analysis. J Pestic Sci. 2011;36(2):248-51. doi: 10.1584/jpestics.G10-79.

Zhang H, Shen Y, Bao Y, He Y, Feng F, Zheng X. Characterization and synergistic antimicrobial activities of food-grade dilution-stable microemulsions against Bacillus subtilis. Food Res Int. 2008;41(5):495-9. doi: 10.1016/j.foodres.2008.02.006.

Zhang H, Shen Y, Weng P, Zhao G, Feng F, Zheng X. Antimicrobial activity of a food-grade fully dilutable microemulsion against Escherichia coli and Staphylococcus aureus. Int J Food Microbiol. 2009;135(3):211-5. doi: 10.1016/j.ijfoodmicro.2009.08.015, PMID 19717202.

Mirani A, Kundaikar H, Velhal S, Patel V, Bandivdekar A, Degani M, Patravale V. Tetrahydrocurcumin-loaded vaginal nanomicrobicide for prophylaxis of HIV/AIDS: in silico study, formulation development, and in vitro evaluation. Drug Deliv Transl Res. 2019;9(4):828-47. doi: 10.1007/s13346-019-00633-2, PMID 30900133.

Lin CC, Lin HY, Chi MH, Shen CM, Chen HW, Yang WJ, Lee MH. Preparation of curcumin microemulsions with food-grade soybean oil/lecithin and their cytotoxicity on the HepG2 cell line. Food Chem. 2014;154:282-90. doi: 10.1016/j.foodchem.2014.01.012, PMID 24518344.

Chen YC, Chen BH. Preparation of curcuminoid microemulsions from Curcuma longa L. to enhance inhibition effects on growth of colon cancer cells HT-29. RSC Adv. 2018;8(5):2323-37. doi: 10.1039/C7RA12297G.

Das S, Lee SH, Chia VD, Chow PS, Macbeath C, Liu Y, Shlieout G. Development of microemulsion based topical ivermectin formulations: pre-formulation and formulation studies. Colloids Surf B Biointerfaces. 2020;189:110823. doi: 10.1016/j.colsurfb.2020.110823.

Khokhra S, Diwan A. Microemulsion based transdermal Drug delivery of tea tree Oil. Int J Drug Dev Res. 2011;3(1):191-8.

Zhang L, Zhu W, Yang C, Guo H, Yu A, Ji J, Gao Y, Sun M, Zhai G. A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting. Int J Nanomedicine. 2012;7:151-62. doi: 10.2147/IJN.S27639, PMID 22275831.

Sharma S, Ganju E, Upmanyu N, Jain P. Therapeutic microemulsion of curcumin for the management of osteoarthritis. J Drug Delivery Ther. 2018;8(5-s):341-7. doi: 10.22270/jddt.v8i5-s.1989.

Ahmad N, Ahmad R, Al-Qudaihi A, Alaseel SE, Fita IZ, Khalid MS, Pottoo FH. Preparation of a novel curcumin nanoemulsion by ultrasonication and its comparative effects in wound healing and the treatment of inflammation. RSC Adv. 2019;9(35):20192-206. doi: 10.1039/C9RA03102B.

Solanki SS, Sarkar B, Dhanwani RK. Microemulsion drug delivery system: for bioavailability enhancement of ampelopsin. ISRN Pharm. 2012;2012:108164. doi: 10.5402/2012/108164, PMID 22830055.

Kuang J, Gao J, Xie S, Lei Q, Fang W, Xie H, Lu X. Phase behaviors and curcumin encapsulation performance of Gemini surfactant microemulsion. J Mol Liq. 2020;315. doi: 10.1016/j.molliq.2020.113786, PMID 113786.

ERDAL MS, GÜRBÜZ A, Birteksöz Tan S, GÜNGÖR S, ÖZSOY Y. In vitro skin permeation and antifungal activity of naftifine microemulsions. Turk J Pharm Sci. 2020;17(1):43-8. doi: 10.4274/tjps.galenos.2018.87699, PMID 32454759.

Chryssanthou E, Cuenca-Estrella M. Comparison of the antifungal susceptibility testing subcommittee of the European committee on antibiotic susceptibility testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. J Clin Microbiol. 2002;40(10):3841-4. doi: 10.1128/JCM.40.10.3841-3844.2002, PMID 12354895.

Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163-75. doi: 10.1038/nprot.2007.521, PMID 18274517.

Rahdar A, Hajinezhad MR, Sargazi S, Zaboli M, Barani M, Baino F, Bilal M, Sanchooli E. Biochemical, ameliorative and cytotoxic effects of newly synthesized curcumin microemulsions: evidence from in vitro and in vivo Sstudies. Nanomaterials (Basel). 2021;11(3):817. doi: 10.3390/nano11030817, PMID 33806829.

El-Kamel A.H. In vitro and in vivo evaluation of Ppluronic F127-based ocular delivery system for timolol maleate. Int J Pharm.. 2002;241(1):47-55. doi: 10.1016/s0378-5173(02)00234-x, PMID 12086720.

Jaszczak M, Wach R, Maras P, Dudek M, Kozicki M. Substituting gelatine with Ppluronic F-127 matrix in 3D polymer gel dosimeters can improve nuclear magnetic resonance, thermal and optical properties. Phys Med Biol.. 2018;63(17):175010:175010. doi: 10.1088/1361-6560/aad9d5.

Patel MR, Patel RB, Parikh JR, Patel BG. Novel microemulsion-based gel formulation of tazarotene for therapy of acne. Pharm Dev Technol. 2016;21(8):921-32. doi: 10.3109/10837450.2015.1081610. PMID 26334480.

Shetty T, Dubey A, Ravi G, Hebbar S, Shastry C, Charyulu N. Antifungal and Aantioxidant Ttherapy for the Ttreatment of Ffungal Iinfection with Mmicroemulsion Ggel Ccontaining Ccurcumin and Vvitamin C. Asian J Pharm.. 2017;11(4):717-725.

Bachhav YG, Patravale VB. Microemulsion-Bbased Vvaginal Ggel of Cclotrimazole: Fformulation, In vitro Eevaluation, and Sstability Sstudies. AAPS PharmSciTech. 2009;10(2):476-481. doi: 10.1208/s12249-009-9233-2, PMID 19381825.

Ferreira SBS, Slowik KM, Castro Hoshino LV, Baesso ML, Murdoch C, Colley HE et al, Bruschi ML. Mucoadhesive emulgel systems containing curcumin for oral squamous cell carcinoma treatment: Ffrom pre-formulation to cytotoxicity in tissue-engineering oral mucosa. Eur J Pharm Sci.. 2020;151:105372:105372. doi: 10.1016/j.ejps.2020.105372.

Kadota K, Nogami S, Uchiyama H, Tozuka Y. Controlled release behavior of curcumin from kappa-carrageenan gels with flexible texture by the addition of metal chlorides. Food Hydrocoll.. 2020;101. doi: 10.1016/j.foodhyd.2019.105564:, 105564PMID 105564.

Rodero CF, Fioramonti Calixto GM, Cristina dos Santos K, Sato MR, Aparecido dos Santos Ramos M, Miró MS et al, Rodríguez E, Vigezzi C, Bauab TM, Sotomayor CE, Chorilli M. Curcumin-Lloaded Lliquid Ccrystalline Ssystems for Ccontrolled Ddrug Rrelease and Iimproved Ttreatment of Vvulvovaginal Ccandidiasis. Mol Pharm.. 2018;15(10):4491-4504. doi: 10.1021/acs.molpharmaceut.8b00507, PMID 30184431.

Hussain A, Samad A, Singh SK, Ahsan MN, Haque MW, Faruk A, Ahmed FJ Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Drug Deliv. 2016;23(2):642-47. doi: 10.3109/10717544.2014. 933284. PMID 25013957.

Srivastava N, Patel DK, Rai VK, Pal A, Yadav NP. Development of emulgel formulation for vaginal candidiasis: Ppharmaceutical characterization, in vitro and in vivo evaluation. J Drug Deliv Sci Technol.. 2018;48:490-498. doi: 10.1016/j.jddst.2018.10.013.

El-Sheridy NA, Ramadan AA, Eid AA, El-Khordagui LK. Itraconazole lipid nanocapsules gel for dermatological applications: in vitro characteristics and treatment of induced cutaneous candidiasis. Colloids Surf B Biointerfaces. 2019;181:623-631. doi: 10.1016/j.colsurfb.2019.05.057, PMID 31202972.

Raesi Vanani Vanani AA, Mahdavinia M, Kalantari H, Khoshnood S, Shirani M. Antifungal effect of the effect of Securigera sSecuridaca L. vaginal gel on Candida species. Curr Med Mycol.. 2019;.5(3): 31-35. DOIdoi: 10.18502/cmm.5.3.1744, PMID 31850394.

Abd Ellah NH, Abdel-Aleem JA, Abdo MN, Abou-Ghadir OF, Zahran KM, Hetta HF. Efficacy of ketoconazole gel-flakes in treatment of vaginal candidiasis: Fformulation, in vitro and clinical evaluation. Int J Pharma. 2019;567:118472:118472. doi: 10.1016/j.ijpharm.2019.118472.

Bhalke, R, Kulkarni, S. S., Kendre P. et alet al.. A facile approach to fabrication and characterization of novel herbal microemulsion-based UV shielding cream. Futur J Pharm Sci 6, 76. (2020). Doi: https://doi;6:76. org/10.1186/s43094-020-00075-5doi: 10.1186/s43094-020-00075-5.



How to Cite

BAIRAGI, G. R., and V. P. PATEL. “FORMULATION AND DEVELOPMENT OF CURCUMIN BASED EMULGEL IN TREATMENT AND RECURRENCE OF VAGINAL CANDIDIASIS”. International Journal of Current Pharmaceutical Research, vol. 13, no. 5, Sept. 2021, pp. 89-99, doi:10.22159/ijcpr.2021v13i5.1900.



Original Article(s)